HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER		Author Keyword(s) Vol Page [Advanced]

This Article Full Text Full Text (PDF) All Versions of this Article: gut.2005.079905v1 55/5/715    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this link to a friend Similar articles in this journal Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Price, D A Articles by Donaldson, P T Search for Related Content PubMed PubMed Citation Articles by Price, D A Articles by Donaldson, P T

Apolipoprotein 3 allele is associated with persistent hepatitis C virus infection

¹ Liver Research Group, School of Clinical Medical Sciences and School of Clinical and Laboratory Sciences, Faculty of Medical Sciences, University of Newcastle, Newcastle upon Tyne, UK, and Department of Infectious Diseases, Newcastle General Hospital, Newcastle upon Tyne, UK
² Liver Research Group, School of Clinical Medical Sciences and School of Clinical and Laboratory Sciences, Faculty of Medical Sciences, University of Newcastle, Newcastle upon Tyne, UK
³ Department of Infectious Diseases, Newcastle General Hospital, Newcastle upon Tyne, UK
⁴ Hepatology Centre, St James Hospital, Dublin, Ireland
⁵ Institute for Aging and Health, School of Neurology, Neuroscience and Psychiatry, University of Newcastle, Newcastle upon Tyne, UK

Correspondence to:
Correspondence to:
Professor M F Bassendine
School of Clinical Medical Sciences (Hepatology), Faculty of Medical Sciences, University of Newcastle, Framlington Place, Newcastle upon Tyne NE2 4HH, UK; m.bassendine{at}ncl.ac.uk

ABSTRACT
Background: Host genetic factors may significantly influence the ability to clear hepatitis C virus (HCV) following infection. HCV is associated with very low density lipoproteins (VLDL) and low density lipoproteins (LDL) in the host’s circulation. Apolipoprotein E (APOE) is found in VLDL and binds to potential receptors involved in HCV entry into cells, the LDL receptor, and the scavenger receptor protein SR-B1. The APOE gene is polymorphic with three alleles coding for three isoforms: Apo-2, Apo-3, and Apo-4. The aim of this study was to assess if these functional polymorphisms determine disease outcome in HCV infected individuals.

Methods: The APOE genotype was determined in 420 Northern European patients with evidence of exposure to HCV. Genotype and allele distribution were compared with those of 288 healthy controls and progression of liver disease and viral clearance were analysed according to APOE allele status.

Results: The APOE*E2 and APOE*E4 alleles were both associated with a reduced likelihood of chronic infection (odds ratio (OR) 0.39 (95% confidence interval (CI) 0.211–0.728), p = 0.003; and OR 0.6 (95% CI 0.38–0.96), p = 0.032) and there was a notable absence of the E2E2 genotype in the HCV antibody positive group compared with the control population (p = 0.0067). Overall the genotypes carrying the E2 allele (E2,E3 and E2,E4) were associated with the equivalent of a 3–5-fold reduction in the risk of chronic HCV infection (genotype relative risk 0.36 and 0.20, respectively).

Conclusion: This study indicates that functional APOE gene polymorphisms may be a determinant of outcome in HCV infection. We hypothesise that the E2 allele may protect against viral persistence via defective binding of HCV lipoviral particles to the cellular receptors involved in entry of these infectious particles.

Abbreviations: HCV, hepatitis C virus; VLDL, very low density lipoprotein; LDL, low density lipoprotein; LDLr, low density lipoprotein receptor; ApoE, apolipoprotein E; APOB, apolipoprotein B; LVP, lipoviral particle; PCR, polymerase chain reaction; IVDU, intravenous drug user; HIV, human immunodeficiency virus

Keywords: hepatitis C; genetic susceptibility; case control association study; chronic infection; acute infection; lipid metabolism

This article has been cited by other articles:

				T. D. Burt, B. K. Agan, V. C. Marconi, W. He, H. Kulkarni, J. E. Mold, M. Cavrois, Y. Huang, R. W. Mahley, M. J. Dolan, et al. Apolipoprotein (apo) E4 enhances HIV-1 cell entry in vitro, and the APOE {varepsilon}4/{varepsilon}4 genotype accelerates HIV disease progression PNAS, June 24, 2008; 105(25): 8718 - 8723. [Abstract] [Full Text] [PDF]

				M. Jones and J. S Owen How does interferon inhibit HCV cell entry? Gut, May 1, 2008; 57(5): 573 - 574. [Full Text] [PDF]

				K.-S. Chang, J. Jiang, Z. Cai, and G. Luo Human Apolipoprotein E Is Required for Infectivity and Production of Hepatitis C Virus in Cell Culture J. Virol., December 15, 2007; 81(24): 13783 - 13793. [Abstract] [Full Text] [PDF]

				S. Ryder Do high lipids help clearance of hepatitis C? Gut, August 1, 2007; 56(8): 1044 - 1045. [Full Text] [PDF]

				J.-M. Petit, A. Minello, L. Duvillard, V. Jooste, S. Monier, V. Texier, J.-B. Bour, A. Poussier, P. Gambert, B. Verges, et al. Cell surface expression of LDL receptor in chronic hepatitis C: correlation with viral load Am J Physiol Endocrinol Metab, July 1, 2007; 293(1): E416 - E420. [Abstract] [Full Text] [PDF]

				O. Diaz, F. Delers, M. Maynard, S. Demignot, F. Zoulim, J. Chambaz, C. Trepo, V. Lotteau, and P. Andre Preferential association of Hepatitis C virus with apolipoprotein B48-containing lipoproteins. J. Gen. Virol., October 1, 2006; 87(Pt 10): 2983 - 2991. [Abstract] [Full Text] [PDF]